Clinical characteristics of the patients infected with Carbapenem-resistant Enterobacteriaceae

被引：0
|
作者：
Chen, Ya-Lan [1 ,2 ]
Tsai, Shu-Juan [1 ,2 ]
Tsai, Chen-Chi [1 ,3 ]
Lin, Jia-Lin [1 ,2 ]
Su, Hsiu-Lun [2 ]
Chuang, Hui-Ying [1 ,2 ]
Shen, Mei-Lan [4 ]
Lay, Chorng-Jang [1 ,3 ]
机构：
[1] Buddhist Dalin Tzu Chi Gen Hosp, Infect Control Comm, Chiayi, Taiwan
[2] Buddhist Dalin Tzu Chi Gen Hosp, Dept Nursing, Chiayi, Taiwan
[3] Buddhist Dalin Tzu Chi Gen Hosp, Dept Med, Div Infect Dis, Chiayi, Taiwan
[4] Buddhist Dalin Tzu Chi Gen Hosp, Dept Clin Pathol, Chiayi, Taiwan
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PS 212
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [31] Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms
    Lu, Qiong
    Li, Guo-Hua
    Qu, Qiang
    Zhu, Hai-Hong
    Luo, Yue
    Yan, Han
    Yuan, Hai-Yan
    Qu, Jian
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 1979 - 1988
  • [32] Carbapenem-Resistant Enterobacteriaceae in Pediatric Patients: Epidemiology and Risk Factors
    Dirajlal-Fargo, Sahera
    DeBiasi, Roberta
    Campos, Joseph
    Song, Xiaoyan
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (04): : 447 - 449
  • [33] Patients with carbapenem-resistant Enterobacteriaceae in emergency room; is this a real problem?
    Salomao, Matias C.
    Freire, Maristela P.
    Levin, Anna Sara S.
    FUTURE MICROBIOLOGY, 2019, 14 (18) : 1527 - 1530
  • [34] Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy
    Eilertson, Brandon
    Cober, Eric
    Richter, Sandra S.
    Perez, Federico
    Salata, Robert A.
    Kalayjian, Robert C.
    Watkins, Richard R.
    Doi, Yohei
    Kaye, Keith S.
    Evans, Scott
    Fowler, Vance G., Jr.
    Bonomo, Robert A.
    DeHovitz, Jack
    Kreiswirth, Barry
    van Duin, David
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (04): : 1 - 6
  • [35] Clinical Outcome of Patients on Ceftazidime-avibactam and Combination Therapy in Carbapenem-resistant Enterobacteriaceae
    Nagvekar, Vasant
    Shah, Anand
    Unadkat, Vrajeshkumar P.
    Chavan, Amol
    Kohli, Ruhi
    Hodgar, Shailendra
    Ashpalia, Aashita
    Patil, Niranjan
    Kamble, Rahul
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (07) : 780 - 784
  • [36] Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
    Perez, Federico
    Van Duin, David
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2013, 80 (04) : 225 - 233
  • [37] Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia
    Seo, Hyeonji
    Lee, Seung Cheol
    Chung, Hyemin
    Ra, Sang Hyun
    Sung, Heungsup
    Kim, Mi-Na
    Jung, Jiwon
    Kim, Min Jae
    Kim, Sung-Han
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Woo, Jun Hee
    Chong, Yong Pil
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (04)
  • [38] Prevalence and drug resistance characteristics of carbapenem-resistant Enterobacteriaceae in Hangzhou, China
    Yang, Yan
    Chen, Jian
    Lin, Di
    Xu, Xujian
    Cheng, Jun
    Sun, Changgui
    FRONTIERS OF MEDICINE, 2018, 12 (02) : 182 - 188
  • [39] Molecular and clinical characteristics of carbapenem-resistant Enterobacteriaceae isolates collected at a tertiary hospital in northern China
    Wang, Hua
    Yan, Zhi
    Mu, Lan
    Gao, Xiang-Yu
    Li, Jia-Ying
    Hu, Zhi-De
    Wang, Jun-Rui
    Zheng, Wen-Qi
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2023, 117 (01) : 55 - 57
  • [40] Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics
    Abboud, C. S.
    Monteiro, J.
    Stryjewski, M. E.
    Zandonadi, E. C.
    Barbosa, V.
    Dantas, D.
    Sousa, E. E.
    Fonseca, M. J.
    Jacobs, D. M.
    Pignatari, A. C.
    Kiffer, C.
    Rao, G. G.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 47 (05) : 386 - 390
12345